A systematic review of evidence on the positive influence of saffron (Crocus sativus L.) on multiple sclerosis (MS) symptoms has raised concerns about the possible risk of bias (RoB) due to selective reporting of outcomes and adverse reactions.
A comparison of gut mycobiome of multiple sclerosis (MS) subjects with a healthy control group has identified correlations between specific mycobiome and the autoimmune disease.
Probiotic supplementation can slow down the progression of Multiple Sclerosis (MS), suppress associated depression, and improve the general health of patients, a review of relevant literature concludes.
A new study in mice has concluded that a compound found in the peels of fruits such as apples and prunes, and some herbs, can reduce and even reverse damage to brain cells in patients with Multiple Sclerosis (MS).
Findings from a new genetic study support previous data linking lower vitamin D levels with an increased risk of multiple sclerosis (MS), say the team behind the paper.
High levels of vitamin D may be associated with reduced disease activity and a lower risk of progression for people with multiple sclerosis (MS), according to new research.
A single dose of calcitriol, the active hormone form of vitamin D, followed by ongoing vitamin D supplementation could help to halt the progression of multiple sclerosis, according to new research in mice.
Consumption of the natural supplement Gingko biloba does not offer any cognitive functioning benefits in people with multiple sclerosis, say researchers.
Supplementation with omega-3 fatty acids has no benefit on the disease activity of multiple sclerosis, according to data from a new clinical trial the authors acknowledged was underpowered.
Supplements of vitamin D at ‘critical time periods’ may be key to reducing the risk of multiple sclerosis, according to a new study from the UK and Canada.
Higher levels of vitamin D in the body may reduce the risk of
developing the neurological disease multiple sclerosis by as much
as 62 per cent, Harvard researchers report.
Women who take vitamin D supplements through multivitamins are 40
per cent less likely to develop multiple sclerosis (MS) than women
who do not take supplements, shows a study published today.
Nascobal, the drug produced by Nastech Pharmaceutical and designed
to treat vitamin B12 deficiency, has been granted approval by the
FDA for use in the treatment of patients suffering from HIV, AIDS,
multiple sclerosis and Crohn's...
A compound found in the spice turmeric could help slow the
progression of the debilitating disease multiple sclerosis (MS),
according to preliminary studies on rats.
